Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers-Reference-Cited by-同舟云学术

Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers

Published:2016-06-22 Issue:9-10 Volume:55 Page:1168-1174
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Sebbagh Sihem¹,Roux Julia²,Dreyer Chantal¹,Neuzillet Cindy¹,de Gramont Armand¹,Orbegoso Cecilia¹,Hentic Olivia³,Hammel Pascal³,de Gramont Aimery⁴,Raymond Eric¹,André Thierry²,Chibaudel Benoist⁴,Faivre Sandrine¹

Affiliation:

1. Department of Medical Oncology, Beaujon University Hospital, Assistance Publique-Hôpitaux De Paris (AP-HP), Clichy, France;

2. Department of Medical Oncology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux De Paris (AP-HP), Paris, France;

3. Department of Gastroenterology and Pancreatology, Beaujon University Hospital, Assistance Publique-Hôpitaux De Paris (AP-HP), Clichy, France;

4. Institut Hospitalier Franco-Britannique, Levallois-Perret, France

Funder

FNAB

AAREC

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2016.1191670

Reference28 articles.

1. Cholangiocarcinoma

2. Biliary Tract Cancers

3. Chemotherapy for cholangiocarcinoma: An update

4. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

5. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second line chemotherapy for advanced biliary cancer: FOLFOX versus FOLFIRI: Analysis of retrospective and prospective data;Journal of Modern Oncology;2024-07-03

2. Treatment of Metastatic Biliary Cancers With Irinotecan and 5-Fluorouracil Based Chemotherapy After Platinum/Gemcitabine Progression: A Systematic Review and Meta-Analysis;Clinical Colorectal Cancer;2024-06

3. MiR-380 inhibits the proliferation and invasion of cholangiocarcinoma cells by silencing LIS1;Cancer Cell International;2024-04-06

4. FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabine-based chemotherapy;Frontiers in Oncology;2023-11-30

5. Multidisciplinary Treatment of Patients with Progressive Biliary Tract Cancer after First-Line Gemcitabine and Cisplatin: A Single-Center Experience;Cancers;2023-05-03